Report cover image

U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published Apr 01, 2023
Length 456 Pages
SKU # DAABD17954855

Description

U.S. Pancreatic Cancer Diagnostics Market - Industry Trends and Forecast to 2030


The U.S. pancreatic cancer diagnostics market is projected to register a healthy CAGR of 8.3% in the forecast period of 2022 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2022 to 2030.

Market Segmentation
U.S. Pancreatic Cancer Diagnostics Market, By Test Type (Imaging Test, Biopsy, Blood Test, Genomic Test, and Others), Cancer Stage (Stage 0, Stage I, Stage II, Stage III, and Stage IV), Tumor Type (Exocrine Tumors and Neuroendocrine Tumors), Product (Instrument-Based Products, Platform-Based Products, Kits and Reagents, and Other Consumables), Technology (Fluorescent In Situ Hybridization, Next Generation Sequencing, Fluoroimmunoassay, Comparative Genomic Hybridization, Immunohistochemical, and Others), Application (Screening, Diagnostic and Predictive, Prognostic, and Research), End User (Hospitals, Diagnostic Centers, Cancer Research Centers, Academic Institutes, Ambulatory Surgical Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Region (Southern U.S., Western U.S., Mid-Western U.S., and North-Eastern U.S.) Industry Trends and Forecast to 2030

Some of the major factors contributing to the growth of the U.S. pancreatic cancer diagnostics market are:

• Novel technological advancements in pancreatic diagnostics
• Growing awareness of pancreatic cancer and increasing healthcare expenditure

Market Players
Some of the major market players operating in the U.S. pancreatic cancer diagnostics market are:

• Agilent Technologies, Inc.
• BD
• Biological Dynamics
• CANON MEDICAL SYSTEMS CORPORATION
• ClearNote Health
• CTK Biotech, Inc.
• Danaher.
• Exact Sciences Corporation
• F. Hoffman- La Roche Ltd
• FUJIFILM Holdings America Corporation
• GRAIL
• Immunovia
• Koninklijke Philips N.V.
• Laboratory Corporation of America Holdings
• MP BIOMEDICALS
• Myriad Genetics, Inc.
• QIAGEN
• Quest Diagnostics Incorporated
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

456 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Secondary Sources
2.11 Assumptions
3 Executive Summary
4 U.S. Chronic Pancreatitis Testing Market
4.1 Chronic Pancreatitis
4.2 Laboratory Testing
4.3 Chronic Pancreatitis Diagnose
4.4 Pancreatic Function Tests
4.4.1 Indirect Pancreatic Function Tests
4.4.2 Direct Pancreatic Function Tests
5 Premium Insights
5.1 Pestel Model
5.2 Porter's Five Forces
5.3 Epidemiology
6 U.S. Pancreatic Cancer Diagnostics Market, Industry Insights
7 U.S. Pancreatic Cancer Diagnostics Market, Regulations
8 Market Overview
8.1 Drivers
8.1.1 Growth In The Prevalence Of Pancreatic Cancer
8.1.2 Novel Technological Advancements In Pancreatic Diagnostics
8.1.3 Rising Preference For Preventive Health Check-ups
8.1.4 Increase In Awareness Regarding Pancreatic Cancer
8.2 Restraints
8.2.1 Strict Regulations And Standards For The Approval And Commercialization Of Pancreatic Cancer Diagnostic Products
8.2.2 Late Diagnosis And Poor Prognosis Of Pancreatic Cancer
8.3 Opportunities
8.3.1 Increase In Diagnostic Products For Pancreatic Cancer
8.3.2 Rise In Healthcare Expenditure For Cancer Diagnosis And Treatment
8.3.3 Government Initiatives Toward Pancreatic Cancer Diagnostics
8.4 Challenges
8.4.1 Increased Cost, Safety, And Convenience Issues
8.4.2 Lack Of Skilled And Certified Professionals
9 Impact Of Covid-19
9.1 Overview
9.2 Demand Surge For Medical Diagnostic
9.3 Growth In Government Spending On Healthcare
9.4 Strategic Initiatives By Key Players
9.5 Increase In The Price Of Tests Kits And Reagents
10 Outlook And Trend Of The Market After Covid -19
11 U.S. Pancreatic Cancer Diagnostics Market, By Test Type
11.1 Overview
11.2 Imaging Test
11.2.1 Computed Tomography (Ct) Scan
11.2.2 Magnetic Resonance Imaging (Mri)
11.2.3 Mr Cholangiopancreatography
11.2.4 Mr Angiography (Mra)
11.3 Ultrasound
11.3.1 Abdominal Ultrasound
11.3.2 Endoscopic Ultrasound (Eus)
11.4 Cholangiopancreatography
11.4.1 Magnetic Resonance Cholangiopancreatography (Mrcp)
11.4.2 Endoscopic Retrograde Cholangiopancreatography (Ercp)
11.4.3 Precutaneous Transheptic Cholangiopancreatography (Ptc)
11.5 Positron Emission Tomohraphy (Pet)
11.6 Others
11.7 Biopsy
11.8 Ct-guided Needle Biopsy
11.9 Fine Needle Aspiration (Fna)
11.10 Core Needle Biopsy
11.11 Others
11.12 Blood Test
11.13 Liver Function Test
11.14 Tumor Marker
11.14.1 Ca 19-9 Biomarker Test
11.14.2 Carcinoembroynic Antigen (Cea) Test
11.14.3 Ca 50 Marker Test
11.14.4 Others
11.15 Others
11.16 Genomic Test
11.17 Others
12 U.S. Pancreatic Cancer Diagnostics Market, By Cancer Stages
12.1 Overview
12.2 Stage Iv
12.3 Stage Iii
12.4 Stage Ii
12.4.1 Stage Iia
12.4.2 Stage Iib
12.5 Stage I
12.5.1 Stage Ib
12.5.2 Stage Ia
12.6 Stage 0
13 U.S. Pancreatic Cancer Diagnostics Market, By Tumor Type
13.1 Overview
13.2 Exocrine Tumors
13.2.1 Instrument-based Products
13.2.2 Platform-based Products
13.2.3 Kits And Reagents
13.2.4 Other Consumables
13.3 Neuroendocrine Tumors
13.3.1 Instrument-based Products
13.3.2 Platform-based Products
13.3.3 Kits And Reagents
13.3.4 Other Consumables
14 U.S. Pancreatic Cancer Diagnostics Market, By Product
14.1 Overview
14.2 Instrument-based Products
14.2.1 Imaging
14.2.2 Biopsy
14.3 Platform-based Products
14.3.1 Next-generation Sequencing
14.3.2 Microarrays
14.3.3 Pcr
14.3.4 Others
14.4 Kits And Reagents
14.4.1 Ca19-9 Pancreatic Cancer Test Kits
14.4.1.1 Elisa Test Kits
14.4.1.2 Casette Test Kits
14.4.1.3 Others
14.4.2 Cea Pancreatic Cancer Test Kits
14.4.2.1 Elisa Test Kits
14.4.2.2 Casette Test Kits
14.4.2.3 Others
14.5 Others
15 U.S. Pancreatic Cancer Diagnostics Market, By Technology
15.1 Overview
15.2 Fluorescent In Situ Hybridization
15.3 Next Generation Sequencing
15.4 Fluorimmunoassay
15.5 Comparative Genomic Hybridization
15.6 Immunohistochemical
15.7 Others
16 U.S. Pancreatic Cancer Diagnostics Market, By Application
16.1 Overview
16.2 Screening
16.2.1 Instrument-based Products
16.2.2 Platform-based Products
16.2.3 Kits And Reagents
16.2.4 Other Consumables
16.3 Diagnostic And Predictive
16.3.1 Instrument-based Products
16.3.2 Platform-based Products
16.3.3 Kits And Reagents
16.3.4 Other Consumables
16.4 Prognostic
16.4.1 Instrument-based Products
16.4.2 Platform-based Products
16.4.3 Kits And Reagents
16.4.4 Other Consumables
16.5 Research
16.5.1 Instrument-based Products
16.5.2 Platform-based Products
16.5.3 Kits And Reagents
16.5.4 Other Consumables
17 U.S. Pancreatic Cancer Diagnostics Market, By End User
17.1 Overview
17.2 Hospitals
17.3 Diagnostic Centers
17.4 Cancer Research Centers
17.5 Academic Institutes
17.6 Ambulatory Surgical Centers
17.7 Others
18 U.S. Pancreatic Cancer Diagnostics Market, By Distribution Channel
18.1 Overview
18.2 Direct Tender
18.3 Retail Sales
18.4 Others
19 U.S. Pancreatic Cancer Diagnostics Market, By Region
19.1 Overview
19.2 U.S.
19.3 Southern U.S.
19.3.1 Florida
19.3.2 Texas
19.3.3 North Carolina
19.3.4 Georgia
19.3.5 Virginia
19.3.6 Tennessee
19.3.7 Rest Of Southern U.S.
19.4 Western U.S.
19.4.1 Illinois
19.4.2 Ohio
19.4.3 Michigan
19.4.4 Indiana
19.4.5 Missouri
19.4.6 Minnesota
19.4.7 Rest Of Western U.S.
19.5 Mid-western U.S.
19.5.1 California
19.5.2 Washington
19.5.3 Arizona
19.5.4 Colorado
19.5.5 Oregon
19.5.6 Nevada
19.5.7 Rest Of Mid-western U.S.
19.6 North-eastern U.S.
19.6.1 New York
19.6.2 Pennsylvania
19.6.3 New Jersey
19.6.4 Massachusetts
19.6.5 Maryland
19.6.6 Connecticut
19.6.7 Rest Of North-eastern U.S.
20 U.S. Pancreatic Cancer Diagnostics Market: Company Landscape
20.1 Company Share Analysis: Europe
21 Swot Analysis
22 Global Pancreatic Cancer Diagnostics Market
22.1 F. Hoffmann- La Roche Ltd
22.1.1 Company Snapshot
22.1.2 Swot
22.1.3 Revenue Analysis
22.1.4 Product Portfolio
22.1.5 Recent Development
22.2 Koninklijke Philips N.V.
22.2.1 Company Snapshot
22.2.2 Revenue Analysis
22.2.3 Product Portfolio
22.2.4 Recent Developments
22.3 Canon Medical Systems Corporation
22.3.1 Company Snapshot
22.3.2 Revenue Analysis
22.3.3 Product Portfolio
22.3.4 Recent Development
22.4 Grail
22.4.1 Company Profile
22.4.2 Product Portfolio
22.4.3 Recent Development
22.5 Siemens Healthcare Gmbh
22.5.1 Company Snapshot
22.5.2 Revenue Analysis
22.5.3 Product Portfolio
22.5.4 Recent Development
22.6 Agilent Technologies, Inc.
22.6.1 Company Profile
22.6.2 Revenue Analysis
22.6.3 Product Portfolio
22.6.4 Recent Development
22.7 Biological Dynamics
22.7.1 Company Snapshot
22.7.2 Swot
22.7.3 Product Portfolio
22.7.4 Recent Developments
22.8 Bd
22.8.1 Company Snapshot
22.8.2 Revenue Analysis
22.8.3 Product Portfolio
22.8.4 Recent Development 426
List Of Tables
Table 1 U.S. Chronic Pancreatitis Testing: By Blood Markers (No. Of Patients, Type Of Tests Taken During Treatment
Table 1 Approved Diagnostics Of Pancreatic Cancer
Table 2 U.S. Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 3 U.S. Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 4 U.S. Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 5 U.S. Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 6 U.S. Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 7 U.S. Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 8 U.S. Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 9 U.S. Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 10 U.S. Pancreatic Cancer Diagnostics Market, By Cancer Stages, 2021-2030 (Usd Million)
Table 11 U.S. Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 12 U.S. Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 13 U.S. Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 14 U.S. Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 15 U.S. Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 16 U.S. Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 17 U.S. Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 18 U.S. Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 19 U.S. Kits And Reagents In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 20 U.S. Ca19-9 Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 21 U.S. Cea Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 22 U.S. Pancreatic Cancer Diagnostics Market, By Technology, 2021-2030 (Usd Million)
Table 23 U.S. Pancreatic Cancer Diagnostics Market, By Application, 2021-2030 (Usd Million)
Table 24 U.S. Screening In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 25 U.S. Diagnostic And Predictive In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 26 U.S. Prognostic In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 27 U.S. Research In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 28 U.S. Pancreatic Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 29 U.S. Pancreatic Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 30 U.S. Pancreatic Cancer Diagnostics Market, By Region, 2021-2030 (Usd Million)
Table 31 Southern U.S. Pancreatic Cancer Diagnostics Market, By Country, 2021-2030 (Usd Million)
Table 32 Southern U.S. Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 33 Southern U.S. Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 34 Southern U.S. Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 35 Southern U.S. Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 36 Southern U.S. Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 37 Southern U.S. Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 38 Southern U.S. Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 39 Southern U.S. Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 40 Southern U.S. Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 41 Southern U.S. Stage I In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 42 Southern U.S. Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 43 Southern U.S. Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 44 Southern U.S. Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 45 Southern U.S. Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 46 Southern U.S. Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 47 Southern U.S. Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 48 Southern U.S. Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 49 Southern U.S. Kits And Reagents In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 50 Southern U.S. Ca19-9 Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 51 Southern U.S. Cea Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 52 Southern U.S. Pancreatic Cancer Diagnostics Market, By Technology, 2021-2030 (Usd Million)
Table 53 Southern U.S. Pancreatic Cancer Diagnostics Market, By Application, 2021-2030 (Usd Million)
Table 54 Southern U.S. Screening In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 55 Southern U.S. Diagnostic And Predictive In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 56 Southern U.S. Prognostic In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 57 Southern U.S. Research In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 58 Southern U.S. Pancreatic Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 59 Southern U.S. Pancreatic Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 60 Florida Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 61 Florida Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 62 Florida Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 63 Florida Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 64 Florida Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 65 Florida Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 66 Florida Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 67 Florida Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 68 Florida Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 69 Florida Stage I In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 70 Florida Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 71 Florida Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 72 Florida Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 73 Florida Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 74 Florida Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 75 Florida Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 76 Florida Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 77 Florida Kits And Reagents In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 78 Florida Ca19-9 Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 79 Florida Cea Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 80 Florida Pancreatic Cancer Diagnostics Market, By Technology, 2021-2030 (Usd Million)
Table 81 Florida Pancreatic Cancer Diagnostics Market, By Application, 2021-2030 (Usd Million)
Table 82 Florida Screening In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 83 Florida Diagnostic And Predictive In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 84 Florida Prognostic In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 85 Florida Research In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 86 Florida Pancreatic Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 87 Florida Pancreatic Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 88 Texas Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 89 Texas Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 90 Texas Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 91 Texas Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 92 Texas Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 93 Texas Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 94 Texas Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 95 Texas Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 96 Texas Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 97 Texas Stage I In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 98 Texas Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 99 Texas Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 100 Texas Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 101 Texas Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 102 Texas Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 103 Texas Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 104 Texas Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 105 Texas Kits And Reagents In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 106 Texas Ca19-9 Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 107 Texas Cea Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 108 Texas Pancreatic Cancer Diagnostics Market, By Technology, 2021-2030 (Usd Million)
Table 109 Texas Pancreatic Cancer Diagnostics Market, By Application, 2021-2030 (Usd Million)
Table 110 Texas Screening In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 111 Texas Diagnostic And Predictive In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 112 Texas Prognostic In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 113 Texas Research In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 114 Texas Pancreatic Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 115 Texas Pancreatic Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 116 North Carolina Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 117 North Carolina Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 118 North Carolina Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 119 North Carolina Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 120 North Carolina Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 121 North Carolina Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 122 North Carolina Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 123 North Carolina Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 124 North Carolina Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 125 North Carolina Stage I In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 126 North Carolina Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 127 North Carolina Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 128 North Carolina Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 129 North Carolina Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 130 North Carolina Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 131 North Carolina Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 132 North Carolina Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 133 North Carolina Kits And Reagents In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 134 North Carolina Ca19-9 Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 135 North Carolina Cea Pancreatic Cancer Test Kits In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 136 North Carolina Pancreatic Cancer Diagnostics Market, By Technology, 2021-2030 (Usd Million)
Table 137 North Carolina Pancreatic Cancer Diagnostics Market, By Application, 2021-2030 (Usd Million)
Table 138 North Carolina Screening In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 139 North Carolina Diagnostic And Predictive In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 140 North Carolina Prognostic In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 141 North Carolina Research In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 142 North Carolina Pancreatic Cancer Diagnostics Market, By End User, 2021-2030 (Usd Million)
Table 143 North Carolina Pancreatic Cancer Diagnostics Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 144 Georgia Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 145 Georgia Imaging Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 146 Georgia Magnetic Resonance Imaging (Mri) In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 147 Georgia Ultrasound In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 148 Georgia Cholangiopancreatography In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 149 Georgia Blood Test In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 150 Georgia Tumor Marker In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 151 Georgia Biopsy In Pancreatic Cancer Diagnostics Market, By Test Type, 2021-2030 (Usd Million)
Table 152 Georgia Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 153 Georgia Stage I In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 154 Georgia Stage Ii In Pancreatic Cancer Diagnostics Market, By Cancer Stage, 2021-2030 (Usd Million)
Table 155 Georgia Pancreatic Cancer Diagnostics Market, By Tumor Type, 2021-2030 (Usd Million)
Table 156 Georgia Exocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 157 Georgia Neuroendocrine Tumors In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 158 Georgia Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 159 Georgia Instrument-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million)
Table 160 Georgia Platform-based Products In Pancreatic Cancer Diagnostics Market, By Product, 2021-2030 (Usd Million) 197
List Of Figures
Figure 1 U.S. Pancreatic Cancer Diagnostics Market: Segmentation
Figure 2 U.S. Pancreatic Cancer Diagnostics Market: Data Triangulation
Figure 3 U.S. Pancreatic Cancer Diagnostics Market: Droc Analysis
Figure 4 U.S. Pancreatic Cancer Diagnostics Market: U.S. Vs Regional Market Analysis
Figure 5 U.S. Pancreatic Cancer Diagnostics Market: Company Research Analysis
Figure 6 U.S. Pancreatic Cancer Diagnostics Market: Interview Demographics
Figure 7 U.S. Pancreatic Cancer Diagnostics Market: Market Application Coverage Grid
Figure 8 U.S. Pancreatic Cancer Diagnostics Market: Dbmr Market Position Grid
Figure 9 U.S. Pancreatic Cancer Diagnostics Market: Segmentation
Figure 10 Growing Awareness Of Pancreatic Cancer And Increasing Healthcare Expenditure Is Expected To Drive The Growth Of The U.S. Pancreatic Cancer Diagnostics Market From 2023 To 2030
Figure 11 The Imaging Test Segment Is Expected To Account For The Largest Share Of The U.S. Pancreatic Cancer Diagnostics Market In 2023 And 2030
Figure 12 Drivers, Restraints, Opportunities, And Challenges Of The U.S. Pancreatic Cancer Diagnostics Market
Figure 13 U.S. Pancreatic Cancer Diagnostics Market: By Test Type, 2022
Figure 14 U.S. Pancreatic Cancer Diagnostics Market: By Test Type, 2023-2030 (Usd Million)
Figure 15 U.S. Pancreatic Cancer Diagnostics Market: By Test Type, Cagr (2023-2030)
Figure 16 U.S. Pancreatic Cancer Diagnostics Market: By Test Type, Lifeline Curve
Figure 17 U.S. Pancreatic Cancer Diagnostics Market: By Cancer Stages, 2022
Figure 18 U.S. Pancreatic Cancer Diagnostics Market: By Cancer Stages, 2023-2030 (Usd Million)
Figure 19 U.S. Pancreatic Cancer Diagnostics Market: By Cancer Stages, Cagr (2023-2030)
Figure 20 U.S. Pancreatic Cancer Diagnostics Market: By Cancer Stages, Lifeline Curve
Figure 21 U.S. Pancreatic Cancer Diagnostics Market: By Tumor Type, 2022
Figure 22 U.S. Pancreatic Cancer Diagnostics Market: By Tumor Type, 2023-2030 (Usd Million)
Figure 23 U.S. Pancreatic Cancer Diagnostics Market: By Tumor Type, Cagr (2023-2030)
Figure 24 U.S. Pancreatic Cancer Diagnostics Market: By Tumor Type, Lifeline Curve
Figure 25 U.S. Pancreatic Cancer Diagnostics Market: By Product, 2022
Figure 26 U.S. Pancreatic Cancer Diagnostics Market: By Product, 2023-2030 (Usd Million)
Figure 27 U.S. Pancreatic Cancer Diagnostics Market: By Product, Cagr (2023-2030)
Figure 28 U.S. Pancreatic Cancer Diagnostics Market: By Product, Lifeline Curve
Figure 29 U.S. Pancreatic Cancer Diagnostics Market: By Technology, 2022
Figure 30 U.S. Pancreatic Cancer Diagnostics Market: By Technology, 2023-2030 (Usd Million)
Figure 31 U.S. Pancreatic Cancer Diagnostics Market: By Technology, Cagr (2023-2030)
Figure 32 U.S. Pancreatic Cancer Diagnostics Market: By Technology, Lifeline Curve
Figure 33 U.S. Pancreatic Cancer Diagnostics Market: By Application, 2022
Figure 34 U.S. Pancreatic Cancer Diagnostics Market: By Application, 2023-2030 (Usd Million)
Figure 35 U.S. Pancreatic Cancer Diagnostics Market: By Application, Cagr (2023-2030)
Figure 36 U.S. Pancreatic Cancer Diagnostics Market: By Application, Lifeline Curve
Figure 37 U.S. Pancreatic Cancer Diagnostics Market: By End User, 2022
Figure 38 U.S. Pancreatic Cancer Diagnostics Market: By End User, 2023-2030 (Usd Million)
Figure 39 U.S. Pancreatic Cancer Diagnostics Market: By End User, Cagr (2023-2030)
Figure 40 U.S. Pancreatic Cancer Diagnostics Market: By End User, Lifeline Curve
Figure 41 U.S. Pancreatic Cancer Diagnostics Market: By Distribution Channel, 2022
Figure 42 U.S. Pancreatic Cancer Diagnostics Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 43 U.S. Pancreatic Cancer Diagnostics Market: By Distribution Channel, Cagr (2023-2030)
Figure 44 U.S. Pancreatic Cancer Diagnostics Market: By Distribution Channel, Lifeline Curve
Figure 45 U.S. Pancreatic Cancer Diagnostics Market: Company Share 2022 (%) 409

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us